Dr Reddy’s Laboratories Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹5627.4
- Today's High:
- ₹5719.1
- Open Price:
- ₹5627.4
- 52W Low:
- ₹3996.1
- 52W High:
- ₹5986.2
- Prev. Close:
- ₹5612.4
- Volume:
- 16970
Company Statistics
- Market Cap.:
- ₹749.59 billion
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 1114.06%
Company Profile
Dr Reddy’s Laboratories Ltd had its IPO on under the ticker symbol 500124.
The company operates in the sector and industry. Dr Reddy’s Laboratories Ltd has a staff strength of 0 employees.
Stock update
Shares of Dr Reddy’s Laboratories Ltd opened at ₹5627.4 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹5627.4 - ₹5719.1, and closed at ₹5676.25.
This is a +1.14% increase from the previous day's closing price.
A total volume of 16,970 shares were traded at the close of the day’s session.
In the last one week, shares of Dr Reddy’s Laboratories Ltd have increased by +0.27%.
Dr Reddy’s Laboratories Ltd's Key Ratios
Dr Reddy’s Laboratories Ltd has a market cap of ₹749.59 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Dr Reddy’s Laboratories Ltd’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Dr Reddy’s Laboratories Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Dr Reddy’s Laboratories Ltd’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 1114.06%.
In Q3.6666666666667, Dr Reddy’s Laboratories Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Dr Reddy’s Laboratories Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Dr Reddy’s Laboratories Ltd’s profitability.
Dr Reddy’s Laboratories Ltd stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Dr Reddy’s Laboratories Ltd stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹322.85 billion
- Total Liabilities
- ₹85.72 billion
- Operating Cash Flow
- ₹-41373000000.00
- Capital Expenditure
- ₹18.87 billion
- Dividend Payout Ratio
- 0%
Dr Reddy’s Laboratories Ltd ended 2024 with ₹322.85 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹322.85 billion while shareholder equity stood at ₹232.86 billion.
Dr Reddy’s Laboratories Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹85.72 billion in other current liabilities, 833000000.00 in common stock, ₹232.03 billion in retained earnings and ₹5.47 billion in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹66.75 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.00.
Dr Reddy’s Laboratories Ltd’s total current assets stands at ₹204.26 billion while long-term investments were ₹0 and short-term investments were ₹60.97 billion. Its net receivables were ₹72.49 billion compared to accounts payable of ₹0 and inventory worth ₹48.67 billion.
In 2024, Dr Reddy’s Laboratories Ltd's operating cash flow was ₹-41373000000.00 while its capital expenditure stood at ₹18.87 billion.
Comparatively, Dr Reddy’s Laboratories Ltd paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹5676.25
- 52-Week High
- ₹5986.2
- 52-Week Low
- ₹3996.1
- Analyst Target Price
- ₹
Dr Reddy’s Laboratories Ltd stock is currently trading at ₹5676.25 per share. It touched a 52-week high of ₹5986.2 and a 52-week low of ₹5986.2. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹5556.51 and 200-day moving average was ₹4794.65 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.